Active ingredientDarolutamide (Mixture of Diastereomers)Cat. No. P-D021-001CAS 1297538-32-9Family · Pharmaceutical analytical standards
Darolutamide
A non-steroidal antiandrogen that blocks the androgen receptor, approved in 2019 for non-metastatic castration-resistant prostate cancer and later extended to other forms of advanced prostate cancer. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Its chemical structure differs from the other androgen receptor inhibitors: in preclinical studies it crossed the blood-brain barrier less than the others, reaching the brain only to a small extent.
Go to the active ingredient →Active ingredientDarolutamide (Mixture of Diastereomers)Cat. No. P-D021-001CAS 1297538-32-9
Isotopically labelledDarolutamide-D4Cat. No. P-D021-002CAS 2484757-20-0
Isotopically labelledDarolutamide-d7 (Mixture of Diastereomers)Cat. No. P-D021-003
NitrosamineN-Nitroso DarolutamideCat. No. P-D021-004
Impurity2-Chloro-4-(1H-pyrazol-3-yl)benzonitrileCat. No. P-D021-005CAS 1297537-37-1
ImpurityDarolutamide Impurity 1Cat. No. P-D021-006CAS 1401572-44-8
ImpurityDarolutamide Amide ImpurityCat. No. P-D021-007
ImpurityDarolutamide Amino ImpurityCat. No. P-D021-008
ImpurityDarolutamide Carboxilic acid ImpurityCat. No. P-D021-009
ImpurityDarolutamide Despyrazol ImpurityCat. No. P-D021-011CAS 1297537-41-7
ImpurityDarolutamide FragmentCat. No. P-D021-012CAS 1401584-94-8
ImpurityDarolutamide Impurity 2Cat. No. P-D021-013CAS 1297537-33-7
ImpurityDarolutamide Impurity 3Cat. No. P-D021-014CAS 2415967-06-3
ImpurityDarolutamide Impurity 4Cat. No. P-D021-015
ImpurityDarolutamide Impurity 5Cat. No. P-D021-016
ImpurityDarolutamide R-Isomer (Mixture of Diastereomers)Cat. No. P-D021-017CAS 2407645-49-0
ImpurityDarolutamide Terminal fragment ImpurityCat. No. P-D021-018CAS 1297537-45-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.